Yearly conferences on intellectual property law
Intellectual Property in the Pharmaceutical Industry / La propriété intellectuelle dans l’industrie pharmaceutique
10 février 2012 |  |
Morning session
Patents
Chairman: Philippe Ducor, Professeur à la Faculté de droit de l’Université de Genève
| 8h30 | Welcome address Christian Bovet, Doyen de la Faculté de droit de l’Université de Genève Jacques de Werra, Professeur à la Faculté de droit de l’Université de Genève |
| |
| 8h45 | IP challenges in the pharmaceutical industry today and tomorrow Andrew Jenner, Director Innovation, IP&Trade, International Federation of Pharmaceutical Manufacturers & Associations, Geneva |
| |
| 9h15 | Le droit des brevets pharmaceutiques en Europe: quo vadis ? Jean-Christophe Galloux, Professeur à l’Université de Paris II (Panthéon- Assas), directeur de l'Institut de Recherche en Propriété Intellectuelle Henri-Desbois, Paris |
| |
| 9h45 | Coffee Break |
| |
| 10h15 | Patents and access to medicines Peter Beier, Senior Advisor, Department of Public Health, Innovation and Intellectual Property, World Health Organization, Geneva |
| |
| 10h45 | Genetic resources, patents and benefit sharing Ahmed Abdel Latif, Innovation, Technology and Intellectual Property Senior Programme Manager, International Centre for Trade and Sustainable Development, Geneva |
| |
| 11h15 | Roundtable With the speakers and Anatole Krattiger, Director, Global Challenges Division, World Intellectual Property Organization, Geneva Antony Taubman, Director, Intellectual Property Division, World Trade Organization, Geneva |
| |
| 12h15 | Lunch |
| |
Afternoon Session
Beyond Patents
Chairman: François Dessemontet, Professeur honoraire à l’Université de Lausanne
| 13h45 | Les moyens de protection au-delà du droit des brevets: enjeux et
perspectives Philippe Ducor, Professeur à la Faculté de droit de l’Université de Genève |
| |
| 14h00 | Regulatory Data Protection and Market Exclusivity in the
Pharmaceutical Industry Trevor Cook, President of the UK Group of the AIPPI, solicitor, London |
| |
| 14h45 | Coffee Break |
| |
| 15h15 | Challenges of Pharmaceutical Brand Name Creation Dr Hans-Friedrich Czekay, Head of the Global Trade Marks Function, F. Hoffmann-La Roche, Basel |
| |
| 15h45 | Trademark Enforcement Issues in the Pharmaceutical Sector:
How to Balance the Interests? Martin Senftleben, Professor at the VU Amsterdam, lawyer, The Hague |
| |
| 16h15 | Conclusion |
| |